Fumiyuki Hattori

Title: Fumiyuki Hattori: Innovator in Cardiac Cell Research

Introduction

Fumiyuki Hattori is a prominent inventor based in Osaka, Japan, known for his significant contributions to the field of cardiac cell research. With a total of six patents to his name, Hattori has focused on improving the engraftment rates of cardiomyocytes, which are crucial for heart transplantation and regenerative medicine.

Latest Patents

Hattori's latest patents include a method of constructing masses of myocardial cells and a method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses. The first patent aims to enhance the post-transplantation engraftment rate of purified cardiomyocytes by constructing cell masses from these cells. This innovative approach involves dispersing aggregated cardiomyocytes into single cells, which are then cultured under serum-free conditions to promote reaggregation. The second patent focuses on developing a high-yield purification method for cardiomyocytes from a mixture of cells without genetic modification or the addition of special proteins.

Career Highlights

Throughout his career, Hattori has worked with notable organizations, including Daiichi Sankyo Company, Limited and Keio University. His work has been instrumental in advancing the understanding and application of cardiomyocyte technology in medical science.

Collaborations

Hattori has collaborated with esteemed colleagues such as Keiichi Fukuda and Keijiro Sugimura, contributing to the innovative research in cardiac cell development and purification.

Conclusion

Fumiyuki Hattori's work in cardiac cell research exemplifies the impact of innovation in medical science. His patents and collaborations continue to pave the way for advancements in heart transplantation and regenerative therapies.